Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease

计划入组 16 人 · 首次发布于 2017 年 2 月 27 日

Posterior Plating Versus Anterior to Posterior Screws in Fixation of Posterior Column in Pilon Fractures

计划入组 30 人 · 首次发布于 2022 年 3 月 31 日

An Open-label, Observational, Long-term Follow-up Study Evaluating the Safety and Efficacy of RGL-193 Putamen Injection in Patients With Primary Parkinson's Disease

计划入组 6 人 · 首次发布于 2025 年 12 月 12 日

Pituitrin

Rx

Fluocinolone acetonide(Capex, Derma-Smoothe/FS, Derma-smoothe FS, Dermotic, Flac, Iluvien, Neo-synalar, Otixal, Otovel, Retisert, Synalar, Tri-luma, Yutiq)

C₂₄H₃₀F₂O₆

Butamben(Cetacaine, One Touch Reformulated Apr 2009)

C₁₁H₁₅NO₂

BlueRock Therapeutics Advances Bemdaneprocel to Phase III for Parkinson's Disease as Market Projected to Reach $7.0 Billion by 2033

BlueRock Therapeutics' Bemdaneprocel Shows Promise in Parkinson's Disease Phase I Trial

Aspen Neuroscience Advances Commercial-Ready Parkinson's Cell Therapy in Phase 1/2a Trial